Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IrAE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06470971
What this trial is testing

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Yuanquan Yang 40
Testing effectiveness (Phase 2)Looking for participantsNCT07381634
What this trial is testing

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Who this might be right for
Hepatocellular Carcinoma (HCC)IrAE
First Affiliated Hospital of Wenzhou Medical University 134
Not applicableStudy completedNCT06089967
What this trial is testing

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Who this might be right for
CancerImmune-related Adverse Event
Duke University 30
Not applicableLooking for participantsNCT05799898
What this trial is testing

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Complication+1 more
Institut Mutualiste Montsouris 200
Not applicableNot Yet RecruitingNCT07821424
What this trial is testing

Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash

Who this might be right for
Immune Checkpoint Inhibitor-related RashImmune-related Adverse Events
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 72
Testing effectiveness (Phase 2)Looking for participantsNCT07644897
What this trial is testing

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma

Who this might be right for
MelanomaImmune-related Adverse EventImmune Checkpoint Inhibitor
Sun Yat-sen University 55
Not applicableStudy completedNCT05934214
What this trial is testing

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database

Who this might be right for
CancerImmune-related Adverse EventImmune Checkpoint Inhibitor-Related Myocarditis
Groupe Hospitalier Pitie-Salpetriere 141,630